10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
56.09
-2.06 (-3.54%)
At close: Aug 14, 2026, 4:00 PM EDT
56.00
-0.09 (-0.16%)
Pre-market: Aug 17, 2026, 7:09 AM EDT

10x Genomics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
616.91642.82610.79618.73516.41490.49
Revenue Growth
-4.28%5.24%-1.28%19.81%5.28%64.13%
Gross Profit
432.53444.38414.48409.31396.32416.4
Operating Income
-81.18-100.29-193.46-199.75-163.74-52.91
Net Income
-75.13-43.54-182.63-255.1-166-58.22
Earnings Per Share
-0.59-0.35-1.52-2.18-1.46-0.53
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Single Cell Instruments
19.3422.6735.2147.8758.5564.17
Spatial Instruments
27.0534.1157.575.6113.840.3
Single Cell Consumables
370.65363.21372.31420.32400.43390.88
Spatial Consumables
159.54143.98121.1259.2435.1627.86
Services
36.1132.7324.3215.78.437.28
License and Royalty
4.2146.140.32---
Revenue (Total)
616.91642.82610.79618.73516.41490.49

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
552.03523.41393.4388.7429.98587.45
Total Debt
78.884.3682.6195.3795.1881.98
Net Cash (Debt)
473.24439.05310.79293.33334.81505.47
Net Cash Growth
31.27%41.27%5.95%-12.39%-33.76%-15.84%
Net Cash Per Share
3.713.522.582.502.944.58

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
127.09136.056.66-15.2-33.61-21.37
Capital Expenditures
-5.65-5.94-12.39-48.6-131.66-101.28
Free Cash Flow
121.44130.12-5.73-63.8-165.27-122.65
Free Cash Flow Growth
113.51%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
70.11%69.13%67.86%66.15%76.75%84.89%
Operating Margin
-13.16%-15.60%-31.67%-32.28%-31.71%-10.79%
Pretax Margin
-12.14%-6.21%-29.09%-40.21%-31.36%-10.95%
Profit Margin
-12.18%-6.77%-29.90%-41.23%-32.15%-11.87%
FCF Margin
19.68%20.24%-0.94%-10.31%-32.00%-25.01%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
60.1815.86----
PS Ratio
11.853.212.8510.698.0833.92